Document:

exv4w1

Exhibit 4.1

INVESTOR RIGHTS AGREEMENT

     This Investor Rights Agreement (this “Agreement”) is entered into as of July 29,
2004, by and between
SunCoast Holdings, Inc., a Delaware corporation (the “Company”),
Westwind Holding Company,
LLC, a Florida limited liability company (“Investor”), and
Steven M.
Mariano, a resident of Miami-Dade County, Florida, and the majority
stockholder of the Company (the “Majority Stockholder”).

Statement of Purpose

     Contemporaneously with the execution of this Agreement, Investor is purchasing from the
Company 195,694 shares (the “Shares”) of the Company’s Series A Common Stock (the “Series A
Common Stock”) at a purchase price of $10.22 per Share (the “Purchase Price”). As additional
consideration for the purchase of the Shares by Investor, the Company has agreed to grant
Investor certain information rights, anti-dilution rights, preemptive rights, co-sale rights and
other rights, and Investor has agreed to grant Majority Stockholder certain drag along rights,
all on the terms and conditions as more fully set forth herein.

     Now,
Therefore, in consideration of the foregoing Statement of Purpose and the
mutual promises contained herein, the parties hereto hereby agree as follows:

1.
Information Rights. As long as Investor shall own at least one hundred thousand
(100,000) shares of Series A Common Stock, Investor shall have the following rights:

     (a) Inspection. Investor shall have the right during normal business hours upon
reasonable notice to visit and inspect any of the properties of the Company or any of its
subsidiaries and to discuss the affairs, finances and accounts of the Company or any of its
subsidiaries with its officers, and to review such information as is reasonably requested;
provided, however, that the Company shall not be obligated under this
Section 1(a) with
respect
to a competitor of the Company or any of its subsidiaries or with respect to information which
the Board of Directors determines in good faith is confidential and should not, therefore, be
disclosed.

     (b) Visitation Rights. If any Director of the Company elected by holders of the Series
A Common Stock is unable to attend a meeting of the Board of Directors, the Company, upon
request, shall allow another representative designated by Investor to attend such meeting of
the
Board of Directors in a nonvoting capacity, and in connection therewith, the Company shall
give
such representative copies of all notices, minutes, consents and other materials, financial or
otherwise, that the Company provides to its Directors at such meeting.

     (c) Books and Records. The Company will maintain true books and records of
account in which full and correct entries will be made of all its business transactions
pursuant to
a system of accounting established and administered in accordance with generally accepted
accounting principles consistently applied (“GAAP”), and will set aside on its books and
records
all such proper accruals and reserves as shall be required under GAAP; provided, however, that
the financial accounting of its subsidiary, Guarantee Insurance Company, or any other
insurance
company owned by the Company may be reported on a statutory basis of accounting.

1

 

     (d) Audited Financial Statements. No later than one hundred twenty (120) days after
the end of each fiscal year of the Company, the Company will furnish to Investor a
consolidated
balance sheet of the Company, as of the end of such fiscal year, and a statement of income and
a statement of cash flows of the Company for such fiscal year, all prepared in accordance with
GAAP and setting forth in each case in comparative form the figures for the previous fiscal
year,
all in reasonable detail. To the extent requested by Investor, such financial statements shall
be
accompanied by a report and opinion thereon by independent public accountants selected by the
Board of Directors.

     (e) Monthly
Financial Reports; Budget/Reports; Notice of Claims. The Company
will prepare and present to the Board of Directors for review and approval an annual budget
and
operating plans for each fiscal year, which shall include a detailed listing of anticipated
material
capital expenditures. Additionally, the Company shall furnish Investor with (i) copies of such
annual budget as approved by the Board of Directors (and as soon as available, any subsequent
revisions thereto); (ii) as soon as practicable after the end of the first, second and third
fiscal
quarter, and in any event within thirty (30) days thereafter, a balance sheet of the Company
as of
the end of such fiscal quarter and for the current fiscal year to date, including a comparison
to
budget figures for such period, prepared in accordance with GAAP, with the exception that (x)
no notes need be attached to such statements and year-end audit adjustments may not have been
made and (y) the financial accounting of its subsidiary, Guarantee Insurance Company, or any
other insurance company owned by the Company may be reported on a statutory basis of
accounting; and (iii) promptly notify Investor in writing of any claim, dispute or litigation
filed
or threatened against the Company which could have a material adverse effect on the business,
financial condition or prospects of the Company.

2. Anti-Dilution of Investor. Notwithstanding any other rights Investor may have under
this Agreement, including without limitation its preemptive rights pursuant to Section 3 below,
Investor shall have the following specific rights:

     (a) Issuance of Stock Below the Purchase Price. If at any time or from time to time
after the date hereof, the Company issues or sells, or is deemed by the express provisions of
this
Section 2 to have issued or sold, additional shares of Series A Common Stock, other than to
Investor, for an Effective Price (as defined below) less than the Purchase Price, then in
connection with any such sale or issuance Investor shall also be issued that number of
additional
shares of Series A Common Stock determined by subtracting (x) from (y), where (x) is the
number of shares of Series A Common Stock owned by Investor at such time and (y) is the
product obtained by multiplying the number of shares of Series A Common Stock owned by
Investor at such time times a fraction (xx) the numerator of which is the number of shares of
Series A Common Stock issued and outstanding immediately prior to such transaction plus the
number of shares of Series A Common Stock issued pursuant to such transaction and (yy) the
denominator of which shall be the number of shares of Series A Common Stock issued and
outstanding immediately prior to such transaction plus the number of shares of Series A
Common Stock that the aggregate consideration received by the Company pursuant to the
transaction would have purchased at the Purchase Price.

     (b) Determination of Effective Price. For the purpose of making any adjustment
required under this Section 2(b), (i) the consideration received by the Company for any issue
or

2

 

sale of securities will (a) to the extent it consists of cash be computed at the net amount of cash
received by the Company after deduction of any expenses payable by the Company and any underwriting
or similar commissions, compensation or concessions paid or allowed by the Company in connection
with such issue or sale; (b) to the extent it consists of property other than cash, be computed at
the fair market value of that property as reasonably determined in good faith by the Company’s
Board of Directors; and (c) if additional shares of Series A Common Stock, Convertible Securities
(as defined below) or rights or options to purchase additional shares of Series A Common Stock or
Convertible Securities are issued or sold together with other stock or securities or other assets
of the Company for a consideration that covers both, be computed as the portion of the
consideration so received that may be reasonably determined in good faith by the Company’s Board of
Directors to be allocable to such additional shares of Series A Common Stock or Convertible
Securities, and (ii) “Effective Price” means the aggregate consideration received by the Company
for the shares of Series A Common Stock as determined above divided by the number of shares of
Series A Common Stock issued or sold in connection with such transaction (without regard to the
shares of Series A Common Stock issuable to Investor as a result thereof).

     (c) Convertible Securities. For the purpose of the adjustment required under this
Section 2, if the Company issues or sells any Convertible Securities, then in each case the
Company will be deemed to have issued at the time of the issuance such rights or options or
Convertible Securities the maximum number of additional shares of Series A Common Stock
issuable upon exercise or conversion thereof and to have received as consideration for the
issuance of such additional shares of Series A Common Stock an amount equal to the total
amount of the consideration, if any, received by the Company for such issuance of such rights
or
options or Convertible Securities, plus, in the case of Convertible Securities, the minimum
amounts of consideration, if any, payable to the Company (other than by cancellation of
liabilities or obligations evidenced by such Convertible Securities) upon the conversion
thereof.
No further adjustments will be made pursuant to this Section 2 as a result of the actual
issuance
of additional shares of Series A Common Stock on the exercise of any such rights or options or
the conversion of any such Convertible Securities. For purposes of this Agreement, the term
“Convertible Securities” shall mean any security issued by the Company which by its terms is
convertible to shares of Series A Common Stock.

     (d) Inapplicability of Rights. The provisions of this Section 2 shall not apply to
(i)
the issuance to employees, officers or directors of the Company/of options, rights or warrants
to
purchase up to two hundred thousand (200,000) shares of Series A Common Stock pursuant to
stock purchase or stock option plans or other arrangements that are approved by the Board of
Directors, and (ii) shares of Series A Common Stock issued to employees, officers or directors
of
the Company pursuant to the conversion or exercise/of options, rights or warrants to purchase
up
to two hundred thousand (200,000) shares of Series A Common Stock pursuant to stock purchase
or stock option plans or other arrangements that are approved by the Board of Directors.

3. Investor Preemptive Rights.

     (a) Generally. Investor shall have a preemptive right to acquire proportional amounts
of newly issued shares of any equity securities, including any Convertible Securities, up to
Investor’s Pro Rata Share (as defined below) upon the decision of the Board of Directors to issue

3

 

such
equity securities. For purposes of this Section 3, “Pro Rata Share” shall mean the ratio of
(x) to (y), where (x) is the number of shares of Series A Common Stock held by Investor at such
time and (y) is the total number of shares of Series A Common Stock issued and outstanding at such
time plus the total number of shares of Series B Common Stock into which all then issued and
outstanding shares of Series A Preferred Stock are then convertible.

     (b) Procedures. Upon the decision of the Board of Directors to issue equity securities
to which the provisions of this Section 3 apply, the Board of Directors shall provide Investor
written notice of its intention to issue such equity securities, describing the type of equity
securities and the price and the general terms and conditions upon which the Company proposes
to issue such equity securities. Investor shall have ten (10) business days from the date
such
notice is effective to agree in writing to purchase Investor’s Pro Rata Share of such equity
securities for the price and upon the general terms specified in the notice by giving written
notice
to the Company and stating therein the quantity of equity securities to be purchased (not to
exceed Investor’s Pro Rata Share). If Investor elects to exercise its preemptive right to
purchase
shares of such newly issued equity securities, Investor shall have five (5) business days from
the
date of its notice to the Company to deliver to the Company by wire transfer the purchase
price
for such equity securities to be purchased by Investor. If Investor fails to deliver written
notice
to the Company within such ten (10) business day period or if Investor fails to deliver to the
Company the purchase price within such five (5) business day period, then Investor shall
forfeit
its right to purchase such shares of such newly issued equity securities.

     (c) Limitation Upon Waiver. Subject to, and without limiting Investor’s rights under,
Section 2 hereof, shares of any equity securities subject to Investor’s preemptive rights,
which
shares are not acquired by Investor pursuant to this Section 3, may be issued by the Company
to any Persons for a period of one hundred twenty (120) days after being offered in writing to
Investor at a consideration set by the Board of Directors that is not lower than the
consideration
set for the exercise of Investor’s preemptive rights. An offer at a lower consideration or
after the
expiration of one hundred twenty (120) days shall be subject again to Investor’s preemptive
rights as specified in Section 3(a) above.

     (d) Inapplicability of Rights. The preemptive rights established by this Section 3
shall have no application to any of the following:

          (i) equity securities issued by the Company after the date hereof for an aggregate
consideration not in excess of Eight Million Dollars ($8,000,000);

          (ii) the issuance of Series B Common Stock of the Company upon conversion of the Series A
Preferred Stock of the Company;

          (iii) options, warrants or rights to acquire equity securities issued to employees,
officers, directors, consultants, contractors or advisors of the Company or any of its
subsidiaries pursuant to stock purchase or stock option plans or other arrangements that are
approved by the Board of Directors and the issuance of equity securities pursuant to conversion
or exercise of such options, warrants or rights;

4

 

          (iv) equity securities issued or issuable upon conversion of any Convertible Securities,
provided that the provisions of this Section 3 applied to the original issuance of such
Convertible Securities issued after the date hereof and not otherwise excluded under this Section
3(d);

          (v) equity securities issued by the Company for consideration other than cash pursuant to a
merger, consolidation, acquisition or similar business combination;

          (vi) equity securities issued by the Company to stockholders of the Company in connection
with any stock split, stock dividend or recapitalization of the Company;

          (vii) equity securities issued by the Company in connection with any issuance of additional
shares of Series A Common Stock to Investor pursuant to this Agreement;

          (viii) equity securities issued pursuant to any leasing or loan arrangement, including
without limitation any equipment leases, real property leases, loans, debt financing, credit
lines, guaranties of indebtedness, cash price reductions or similar transactions or arrangements
approved by the Board of Directors;

          (ix) equity securities issued by the Company pursuant to any Public Offering; and

          (x) equity securities issued by the Company in connection with strategic transactions
involving the Company and other entities, including without limitation (a) joint ventures,
manufacturing, marketing or distribution arrangements or (b) technology transfer or development
arrangements; provided, that such strategic transactions and the issuance of such equity
securities pursuant thereto have been approved by the Company’s Board of Directors.

4. Investor Co-Sale Rights.

     (a) Generally. With respect to any proposed transfer of shares of any equity security
of the Company to which the right of first refusal provisions (the
“Right of First Refusal”)
set
forth in the Company’s Amended and Restated Bylaws (the
“Bylaws”) apply, upon the
expiration of the Right of First Refusal of the stockholders pursuant to the Bylaws, Investor
shall
have the right to require the proposed transferee to purchase shares of Series A Common Stock
owned by Investor pursuant to this Section 4.

     (b) Exercise. Upon expiration of the stockholders’ Right of First Refusal, the
Company shall send written notice to Investor specifying the number of shares that the Company
and the non-selling stockholders have not elected to purchase pursuant to the Right of First
Refusal and the purchase price and other terms and conditions on which the shares will be sold
to
the proposed transferee. Investor shall have five (5) days from the date of such notice to
notify
the Company in writing that Investor elects to require the transferee to purchase shares of
Series
A Common Stock owned by Investor. In such event, Investor shall have the right to sell to the
proposed transferee, upon the same terms and conditions as the selling stockholder after
giving
effect to any applicable liquidation or other preference and terms and conditions in the
Company’s Amended and Restated Certificate of Incorporation, at a minimum, up to that
number of shares of Series A Common Stock equal to the product of (i) times (ii), where (i) is
a

5

 

fraction (x) the numerator of which is the number of shares of Series A Common Stock owned by
Investor as of the date of the selling stockholder’s notice (as such term is used in the Right of
First Refusal) and (y) the denominator of which is the total number of shares of equity securities
of the Company issued and outstanding as of the date of the selling stockholder’s notice
multiplied by (ii) the number of shares of equity securities of the Company proposed to be sold by
the selling stockholder (as such term is used in the Bylaws) in the selling stockholder’s notice.
The amount of shares of equity securities of the Company to be sold by the selling stockholder
shall be reduced to the extent necessary to provide for such participation in such sale by
Investor.

     (c) Closing. Contemporaneously with the closing of any proposed transfer pursuant to
the Right of First Refusal in which Investor elects to participate pursuant to this Section 4,
Investor shall deliver, free and clear of all liens and encumbrances, to the proposed transferee
certificates representing shares of Series A Common Stock to be sold along with a stock power duly
executed in form sufficient to transfer ownership of such shares on the books and records of the
Company, and shall receive in exchange therefore the consideration to be paid or delivered by the
proposed transferee in respect of such shares of Series A Common Stock as described in the selling
stockholders’ notice, after giving effect to any applicable liquidation or other preference and
terms and conditions in the Company’s Amended and Restated Certificate of Incorporation.

5. Additional Rights And Covenants.

     (a) Most-Favored Nation Status. With respect to any equity securities issued by the
Company to any person after the date hereof until the Company has issued equity securities
after
the date hereof, excluding the Shares, for an aggregate consideration of Eight Million Dollars
($8,000,000), in the event the Company issues any such additional equity securities on terms
and
conditions more favorable to such person than Investor has received from the Company with
respect to the Shares, then the Company shall use its best efforts to take any and all action
necessary or appropriate in order to amend this Agreement or the Certificate of Incorporation
of
the Company in order to provide substantially the same or similar terms and conditions to
Investor with respect to the Shares. The rights provided to Investor pursuant to this Section
5(a)
shall not apply to any issuances of securities or rights to acquire securities specified in
Section
3(d) above.

     (b) Guarantees. The Company shall not, without the prior written approval of
Investor, guarantee or otherwise agree to satisfy any debts or obligations of any officer or
director of the Company.

6. Drag-Along Rights.

     (a) Covenants on Merger. Investor agrees with Majority Stockholder to vote (or grant
any proxy to vote) any shares of the capital stock of the Company now or hereafter directly or
indirectly owned (of record or beneficially) by Investor: (i) in favor of any proposed merger,
consolidation, sale of all or substantially all the Company’s assets or other similar acquisition
transaction which is approved by the Board of Directors of the Company and by Majority
Stockholder, provided that Investor receives the same form and rate of consideration, after giving
effect to any applicable liquidation or other preference and terms and conditions in the

6

 

Company’s Amended and Restated Certificate of Incorporation, and (ii) against any proposed merger,
consolidation, sale of all or substantially all the Corporation’s assets or other similar
acquisition transaction unless such transaction has been approved by Majority Stockholder.

     (b) Covenants on Sale of Stock. Investor agrees with Majority Stockholder that, in
the event Majority Stockholder desires to sell all of the shares of capital stock of the
Company
owned by Majority Stockholder to a proposed purchaser, Majority Stockholder may require
Investor to sell all the shares of capital stock now or hereafter directly or indirectly
owned (of
record or beneficially) by Investor to such proposed purchaser, provided that Investor
receives
the same form and rate of consideration as Majority Stockholder, after giving effect to any
applicable liquidation or other preference and terms and conditions in the Company’s Amended
and Restated Certificate of Incorporation.

     (c) Legend. Investor agrees that all Company share certificates now or hereafter held
by Investor that represent shares of capital stock of the Company subject to this Agreement
will be stamped or otherwise imprinted with a legend to read as follows:

THE SHARES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO AGREEMENTS AND
RESTRICTIONS WITH REGARD TO THE VOTING OF SUCH SHARES AND THEIR TRANSFER,
AS PROVIDED IN THE PROVISIONS OF AN INVESTOR RIGHTS AGREEMENT, A COPY OF
WHICH IS ON FILE IN THE OFFICE OF THE SECRETARY OF THE COMPANY.

7.
Termination Of Rights. The rights established by this Agreement in Sections 1,2,3,
4, 5, and 6 shall not apply to, and shall terminate upon, the effective date of a public offering
pursuant to an effective registration statement filed by the Company (a “Public Offering”).

8. Miscellaneous.

     (a) Adjustments for Stock Splits, Etc. Wherever in this Agreement there is a
reference to a specific number of shares of Series A Common Stock of the Company or to the
Purchase Price, then, upon the occurrence of any subdivision, combination or stock dividend of
such class or series of stock, the specific number of shares and the Purchase Price so
referenced
in this Agreement shall automatically be proportionally adjusted to reflect the affect on the
outstanding shares of such class or series of stock by such subdivision, combination or stock
dividend.

     (b) Governing Law. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without regard to the conflicts of laws
principles thereof.

     (c) Successors and Assigns. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns,
heirs,
executors and administrators of the parties hereto and shall inure to the benefit of and be
enforceable by each person who shall be a holder of the Shares from time to time.

7

 

     (d) Entire Agreement. This Agreement constitutes the full and entire understanding
and agreement between the parties with regard to the subjects hereof and no party shall be
liable
or bound to any other in any manner by any representations, warranties, covenants and
agreements except as specifically set forth herein.

     (e) Severability. In case any provision of this Agreement shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not
in
any way be affected or impaired thereby.

     (f) Amendment and Waiver. This Agreement may be amended or modified only
upon written consent of the parties hereto. The obligations of the Company with respect to
Investor and the rights of Investor may be waived only with the written consent of the
Investor.

     (g) Notices. All notices required or permitted hereunder shall be in writing and shall
be deemed effectively given: (i) upon personal delivery to the party to be notified; (ii) when
sent
by confirmed telex or facsimile if sent during normal business hours of the recipient, if not,
then
on the next business day; (iii) five (5) days after having been sent by registered or
certified mail,
return receipt requested, postage prepaid; or (iv) one (1) day after deposit with a nationally
recognized overnight courier for next day delivery. All communications shall be sent to the
Company and Investor at their respective addresses set forth on the signature page hereof or
at
such other address as the Company or Investor may designate for it by ten (10) days’ advance
written notice to the other parties hereto.

     (h) Expenses. The parties shall pay their respective costs and expenses incurred in
connection with the negotiation, execution, delivery and performance of the Agreement.

     (i) Titles and Subtitles. The titles of the sections and subsections of this
Agreement are for convenience of reference only and are not to be considered in construing this
Agreement.

     (j) Counterparts. This Agreement may be executed in any number of counterparts, each
of which shall be an original, but all of which together shall constitute one document.

     (k) Pronouns. All pronouns contained herein, and any variations thereof, shall be
deemed to refer to the masculine, feminine or neutral, singular or plural, as to the identify of
the parties hereto may require.

[Signatures appear on the following page.]

8

 

     In
Witness Whereof,  the parties hereto have caused this
Investor Rights
Agreement to be executed by their duly authorized representatives as of the date first set
forth above.

	 	 	 	 	 	 	 	 	 	 	 
	COMPANY:	 	 	 	 	PURCHASER:
	 
	 	 	 	 	 	 	 	 	 	 
	Suncoast
Holdings, Inc.	 	 	 	 	Westwind Holding Company, LLC
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Steven M. Mariano
	 	 	 	 	By:  	/s/ Michael
[Illegible last name]
	 	 	 	 	 	 	 	 	 
	 

	 	Steven M. Mariano
	 	 	 	 	 	Name:	 	Michael [Illegible last name]
	 

	 	President
	 	 	 	 	 	Title:	 	President
	 
	 	 	 	 	 	 	 	 	 	 
	Address: 5212 Fisher Island Drive	 	 	 	 	Address: 7560 Commerce Ct

               Sarasota FL 34243
	 

	 	Miami, Florida 33109	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	MAJORITY STOCKHOLDER:	 	 	 	 	 	 	 	 
	 
	/s/ Steven M. Mariano
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	Steven M. Mariano	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Address: 5212 Fisher Island Drive

	 	 	 	 	 	 	 	 
	 

	 	Miami, Florida 33109	 	 	 	 	 	 	 	 

9exv4w2

Exhibit 4.2

WAIVER

This
WAIVER(“Waiver”) is made and entered into as of
March 5, 2008 by and among PATRIOT RISK
MANAGEMENT, INC., a Delaware corporation (the “Company”), WESTWIND HOLDING COMPANY, LLC, a
Florida limited liability company (“Investor”), and STEVEN M. MARIANO, a resident of
Miami-Dade County, Florida, and the majority stockholder of the Company (the “Majority
Stockholder”), said corporation, limited liability company and individual are referred to
herein as the “Parties”.

WHEREAS, Investor owns 215,263 shares of the Company’s Series A Common Stock (the “Series
A Common Stock”) and that certain INVESTOR RIGHTS AGREEMENT dated as of July 29, 2004
(the “Rights Agreement”), which grants Investor certain information rights, anti-dilution
rights, preemptive rights, co-sale rights and other rights, and Investor grants the Majority
Stockholder certain drag-along rights, which rights terminate upon the effective date of a
public offering pursuant to an effective registration statement filed by the Company (“Public
Offering”); and

WHEREAS, the Company is planning to conduct a Public Offering, and in connection therewith
the Investor desires to waive certain rights under the Rights Agreement as set forth herein.

NOW THEREFORE, in consideration of the promises set forth above and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the parties hereto agree
as follows:

	1.	 	Waiver. (a) Investor hereby irrevocably waives any and all of its rights under
Section 2(a) of the Rights Agreement with respect to the issuance by the Company of 169,000
shares of Class A Common Stock at a price of $8.02 per share pursuant to that certain
Purchase and Sale Agreement among the Company, Tarheel Insurance Management
Company and The Tarheel Group, Inc. dated January 1, 2006.
	 
	 	 	(b) Investor hereby irrevocably waives any and all of its rights under Section 2(a)
of the Rights Agreement with respect to the issuance by the Company of shares of
Class A Common Stock or options to purchase shares of Class A Common Stock at a price
of $8.02 per share to officers and directors of the Company.
	 
	2.	 	Effect of Waiver. This Waiver shall be effective from the date
above first written (“Effective Date”), provided however, this waiver shall be void and
have no effect if the Public Offering is not consummated within 12
months of the Effective Date.
	 
	3.	 	Governing Law. This Waiver shall be governed by and construed in accordance
with Section 8(b) of the Rights Agreement.

 

 

	4.	 	Counterparts. This Waiver may be signed in any number of counterparts, each
of which shall be an original, with the same effect as if the signatures thereto and
hereto were upon the same instrument.

IN WITNESS WHEREOF, the parties hereto have caused this Waiver to be executed as set for the below
as of the date first written above.

	 	 	 	 	 	 	 	 	 	 	 
	PATRIOT RISK MANAGEMENT, INC.	 	 	 	WESTWIND HOLDING COMPANY, LLC	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Steven M. Mariano
	 	 	 	By:	 	 	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 

	 	Steven M. Mariano
	 	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	President
	 	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 	 	 
	Address:

	 	401 E. Las Olas Blvd., Suite 1540
	 	 	   Address:  
	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	Fort Lauderdale, Florida 33301	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 

	 	 	 
	MAJORITY STOCKHOLDER
	 	 
	 
	 	 
	/s/ Steven M. Mariano
 

Steven M. Mariano

	 	 

	 	 	 
	Address:

	 	401 E. Las Olas Blvd., Suite 1540
	 

	 	Fort Lauderdale, Florida 33301

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]